17 Sep 2012 12:54
17 September 2012
Immunodiagnostic Systems Holdings PLC
Board Change
Immunodiagnostic Systems Holdings PLC ("IDS" or "the Company" or "the Group"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets,announces that Dr Roger Duggan, Deputy Chairman and Business Development Director, has left the Company following the Annual General Meeting held on Friday 14 September 2012.
Dr Duggan joined RIA (UK), the forerunner to IDS in 1981 and has held the positions of Development Scientist, Laboratory Manager and Scientific Director and became Managing Director following a Management Buy-Out in 1996. Following admission to AIM in 2004 and the subsequent acquisitions of Nordic Bioscience Diagnostics and Biocode-Hycel in 2007, he became CEO of the Group. In 2010, as part of a succession plan, Roger became Deputy Chairman and Business Development Director.
Dr Anthony Martin, Non-executive Chairman of IDS, said, "I would like to extend my sincere thanks to Roger for his contribution to IDS over more than thirty years. He has held a variety of senior roles within the Company since 1981, from helping found the business and has helped build IDS from a small domestic company to an international diagnostics business."
For further information:
Immunodiagnostic Systems Holdings PLC | |
Patrik Dahlen, Chief Executive Officer | Tel : +44 (0)191 5190660 |
Gerard Murray, Finance Director | |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Dr Vijay Barathan | |
FTI Consulting | Tel : +44 (0)207 831 3113 |
Ben Atwell | |
Simon Conway | |
Mo Noonan |